OSUR

OraSure Technologies, Inc. (NASDAQ:OSUR) is a medical device company founded in 2000 and headquartered in Bethlehem, Pennsylvania. The company specializes in developing, manufacturing, and marketing oral fluid diagnostic products and specimen collection devices. Since going public in 1986, OraSure has established itself as a leader in non-invasive diagnostic testing, particularly in HIV testing and sample collection technologies. The company operates globally, serving markets in the United States, Europe, and internationally through two primary business segments: Diagnostics and Molecular Solutions.